CompletedNot Applicable

Significance of Misoprostol-induced Cervical Ripening Prior to Hysteroscopy

Pakistan539 participantsStarted 2022-08-01

Plain-language summary

The goal of this prospective study is to evaluate the efficacy and safety of misoprostol for cervical ripening prior to hysteroscopy

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Non-pregnant women aged 18-45 years. * Confirmed non-pregnancy with a negative urine pregnancy test. * No history of prior surgery or significant cervical pathologies. * Atypical bleeding per vagina. * Infertility. * Suspected uterine pathology. Exclusion Criteria: * Contraindications to prostaglandins, such as: * Allergy to prostaglandins. * Active pelvic infection. * Severe cardiovascular, hepatic, and/or renal disease. * Previous uterine perforation. * Cervical incompetence.

What they're measuring

Cervical Ripening Success Rate

Timeframe: During the hysteroscopy procedure (up to 30 minutes).

Trial details

NCT IDNCT06726278

SponsorHayat Abad Medical Complex, Peshawar

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2024-07-30

View on ClinicalTrials.gov More Hysteroscopy trials